340B Drug Pricing Program
Plaintiffs’ notice of supplemental authority (ECF No. 78) asserts that HHS could reduce the Medicare appeals backlog by agreeing to toll the purported deadline for hospitals to file appeals related to the 340B Drug Discount Program pending the resolution of American Hospital Association v. Azar, No…
In a statement submitted for the hearing, AHA highlighted how hospitals are using savings from the 340B program to provide access to critical services to their communities.
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program
Tax-exempt hospitals in the 340B drug savings program provided $51.7 billion in total benefits to their communities in 2015, the most recent year for which data is available.
WASHINGTON, DC (March 1, 2018) – Hospitals of all kinds provide a full range of benefits to their communities. In a new analysis released today, the American Hospital Associati
In 2015 alone, the most recent year for which data is available, those tax-exempt hospitals participating in the 340B drug savings program provided $51.7B in total benefits to their communities.
Thirty-five state and regional hospital associations today urged the U.S. Court of Appeals for the District of Columbia Circuit to reverse a district court decision and grant a preliminary injunction to stop a nearly 30% Medicare payment reduction for many hospitals in the 340B Drug Pricing Program…